Chemokine CXCL8 promotes HIV-1 replication in human monocyte-derived macrophages and primary microglia via nuclear factor-κB pathway

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Mamik, Manmeet K ^a   Ghorpade, Anuja ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; GAG PROTEIN;

ARTICLE; BINDING SITE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; LUCIFERASE ASSAY; MACROPHAGE; MICROGLIA; MONOCYTE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS DNA CELL DNA INTERACTION; VIRUS ISOLATION; VIRUS REPLICATION; BRAIN; CELL LINE; CYTOLOGY; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; PHYSIOLOGY; PREGNANCY; VIROLOGY;

BRAIN; CELL LINE; FEMALE; HIV CORE PROTEIN P24; HIV-1; HUMANS; INTERLEUKIN-8; MACROPHAGES; MICROGLIA; MONOCYTES; NF-KAPPA B; PREGNANCY; PROMOTER REGIONS, GENETIC; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; SIGNAL TRANSDUCTION; TERMINAL REPEAT SEQUENCES; VIRUS REPLICATION;

EID: 84899754349     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092145     Document Type: Article

References (90)

1. Rich EA, Chen IS, Zack JA, Leonard ML, O'Brien WA (1992) Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 89: 176-183.
2. Zhu T, Muthui D, Holte S, Nickle D, Feng F, et al. (2002) Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol 76: 707-716. (Pubitemid 34033369)
3. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, et al. (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85: 1135-1148. (Pubitemid 26231178)
4. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, et al. (1996) Identification of a major co-receptor for primary isolates of HIV-1 [see comments]. Nature 381: 661-666. (Pubitemid 26197679)
5. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, et al. (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 [see comments]. Nature 381: 667-673. (Pubitemid 26197680)
6. Azevedo FA, Carvalho LR, Grinberg LT, Farfel JM, Ferretti RE, et al. (2009) Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. The Journal of comparative neurology 513: 532-541.
7. Kandel ER, Schwartz JH, Jessell TM (2000) Principles of neural science. New York: McGraw-Hill, Health Professions Division. xli, 1414 p. p.
8. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, et al. (1996) Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. Aids 10: 573-585. (Pubitemid 26162985)
9. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, et al. (1996) Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 39: 705-711. (Pubitemid 26183806)
10. Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R (2011) HIV-1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathog 7: e1002286.
11. Bergamini A, Faggioli E, Bolacchi F, Gessani S, Cappannoli L, et al. (1999) Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1. J Infect Dis 179: 832-842. (Pubitemid 29159328)
12. Lamers SL, Fogel GB, Singer EJ, Salemi M, Nolan DJ, et al. (2012) HIV-1 Nef in macrophage-mediated disease pathogenesis. Int Rev Immunol 31: 432-450.
13. Weinstein JD, Gonzalez ER, Egleton RD, Hunt DA (2013) A paradigm shift for evaluating pharmacotherapy for Alzheimer's disease: the 10-patient screening protocol. The Consultant pharmacist: the journal of the American Society of Consultant Pharmacists 28: 443-454.
14. Gartner S, Liu Y (2002) Insights into the role of immune activation in HIV neuropathogenesis. J Neurovirol 8: 69-75. (Pubitemid 34520888)
15. Yim HC, Li JC, Lau JS, Lau AS (2009) HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: microbial interactions in HIV infection. AIDS 23: 1473-1484.
16. Mirani M, Elenkov I, Volpi S, Hiroi N, Chrousos GP, et al. (2002) HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J Immunol 169: 6361-6368. (Pubitemid 36903484)
17. Puma C, Danik M, Quirion R, Ramon F, Williams S (2001) The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J Neurochem 78: 960-971. (Pubitemid 32823145)
18. Goczalik I, Ulbricht E, Hollborn M, Raap M, Uhlmann S, et al. (2008) Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina. Invest Ophthalmol Vis Sci 49: 4578-4589.
19. Giovannelli A, Limatola C, Ragozzino D, Mileo AM, Ruggieri A, et al. (1998) CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. J Neuroimmunol 92: 122-132. (Pubitemid 29015997)
20. Lane BR, Lore K, Bock PJ, Andersson J, Coffey MJ, et al. (2001) Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol 75: 8195-8202. (Pubitemid 32743692)
21. Carrol ED, Mankhambo LA, Balmer P, Nkhoma S, Banda DL, et al. (2007) Chemokine responses are increased in HIV-infected Malawian children with invasive pneumococcal disease. J Acquir Immune Defic Syndr 44: 443-450. (Pubitemid 46555380)
22. Mamik MK, Ghorpade A (2012) Src homology-2 domain-containing protein tyrosine phosphatase (SHP) 2 and p38 regulate the expression of chemokine CXCL8 in human astrocytes. PLoS One 7: e45596.
23. Chun TW, Engel D, Mizell SB, Ehler LA, Fauci AS (1998) Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J Exp Med 188: 83-91. (Pubitemid 28328608)
24. Nagira M, Sato A, Miki S, Imai T, Yoshie O (1999) Enhanced HIV-1 replication by chemokines constitutively expressed in secondary lymphoid tissues. Virology 264: 422-426.
25. Roth AD, Ramirez G, Alarcon R, Von Bernhardi R (2005) Oligodendrocytes damage in Alzheimer's disease: beta amyloid toxicity and inflammation. Biological research 38: 381-387.
26. Copeland KF, McKay PJ, Newton JJ, Rosenthal KL (1998) Enhancement of HIV-1 replication in human macrophages is induced by CD8+ T cell soluble factors. Clin Exp Immunol 114: 87-93. (Pubitemid 28442818)
27. Cosenza-Nashat M, Zhao ML, Marshall HD, Si Q, Morgello S, et al. (2007) Human immunodeficiency virus infection inhibits granulocyte-macrophage colony-stimulating factor-induced microglial proliferation. J Neurovirol 13: 536-548.
28. Zhang X, Edwards JP, Mosser DM (2009) The expression of exogenous genes in macrophages: obstacles and opportunities. Methods Mol Biol 531: 123-143.
29. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, et al. (1995) Identification of RANTES, MIP-1alpha, and MIP-1beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811-1815.
30. Coffey MJ, Woffendin C, Phare SM, Strieter RM, Markovitz DM (1997) RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages. Am J Physiol 272: L1025-1029.
31. Dolei A, Biolchini A, Serra C, Curreli S, Gomes E, et al. (1998) Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines. Aids 12: 183-190. (Pubitemid 28035159)
32. Gordon CJ, Muesing MA, Proudfoot AE, Power CA, Moore JP, et al. (1999) Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J Virol 73: 684-694. (Pubitemid 28565413)
33. Trkola A, Gordon C, Matthews J, Maxwell E, Ketas T, et al. (1999) The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity. J Virol 73: 6370-6379. (Pubitemid 29327814)
34. Miller-Jensen K, Dey SS, Pham N, Foley JE, Arkin AP, et al. (2012) Chromatin accessibility at the HIV LTR promoter sets a threshold for NF-kappaB mediated viral gene expression. Integr Biol (Camb) 4: 661-671.
35. Borgmann K, Gendelman HE, Ghorpade A (2005) Isolation and HIV-1 infection of primary human microglia from fetal and adult tissue. Methods Mol Biol 304: 49-70.
36. Ghorpade A, Bruch L, Persidsky Y, Chin B, Brown WH, et al. (2005) Development of a rapid autopsy program for studies of brain immunity. J Neuroimmunol 163: 135-144. (Pubitemid 40692957)
37. Ghorpade A, Persidsky Y, Swindells S, Borgmann K, Persidsky R, et al. (2005) Neuroinflammatory responses from microglia recovered from HIV-1-infected and seronegative subjects. J Neuroimmunol 163: 145-156. (Pubitemid 40703897)
38. Ghorpade A, Xia MQ, Hyman BT, Persidsky Y, Nukuna A, et al. (1998) Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J Virol 72: 3351-3361. (Pubitemid 28175580)
39. O'Brien WA, Koyanagi Y, Namazie A, Zhao JQ, Diagne A, et al. (1990) HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 348: 69-73.
40. Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, et al. (1988) Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 167: 1428-1441.
41. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD (2006) Blood brain barrier: Structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacology 1: 223-236. (Pubitemid 44244128)
42. Ghorpade A, Nukuna A, Che M, Haggerty S, Persidsky Y, et al. (1998) Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia. J Virol 72: 3340-3350. (Pubitemid 28175579)
43. Ghorpade A, Persidskaia R, Suryadevara R, Che M, Liu XJ, et al. (2001) Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia. J Virol 75: 6572-6583. (Pubitemid 32578177)
44. Butler SL, Johnson EP, Bushman FD (2002) Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J Virol 76: 3739-3747. (Pubitemid 34250538)
45. Sharkey ME, Teo I, Greenough T, Sharova N, Luzuriaga K, et al. (2000) Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med 6: 76-81. (Pubitemid 30048530)
46. Buzon MJ, Massanella M, Llibre JM, Esteve A, Dahl V, et al. (2010) HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med 16: 460-465.
47. Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, et al. (2000) Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol 74: 3740-3751. (Pubitemid 30180317)
48. Klaver B, Berkhout B (1994) Comparison of 5′ and 3′ long terminal repeat promoter function in human immunodeficiency virus. J Virol 68: 3830-3840.
49. Manthrope M, Fagnani R, Skaper SD, Varon S (1986) An automated colorimetric microassay for neurotrophic factors. Dev Brain Res 25: 191-198. (Pubitemid 16188172)
50. Huang Y, Walstrom A, Zhang L, Zhao Y, Cui M, et al. (2009) Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages. PLoS One 4: e5397.
51. Kim YK, Bourgeois CF, Pearson R, Tyagi M, West MJ, et al. (2006) Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency. EMBO J 25: 3596-3604. (Pubitemid 44264870)
52. Barboric M, Yik JH, Czudnochowski N, Yang Z, Chen R, et al. (2007) Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. Nucleic Acids Res 35: 2003-2012. (Pubitemid 47061666)
53. Fassati A, Goff SP (2001) Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J Virol 75: 3626-3635. (Pubitemid 32246372)
54. Karageorgos L, Li P, Burrell C (1993) Characterization of HIV replication complexes early after cell-to-cell infection. AIDS Res Hum Retroviruses 9: 817-823. (Pubitemid 24017235)
55. Julias JG, Ferris AL, Boyer PL, Hughes SH (2001) Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase. J Virol 75: 6537-6546. (Pubitemid 32578173)
56. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
57. Stroud JC, Oltman A, Han A, Bates DL, Chen L (2009) Structural basis of HIV-1 activation by NF-kappaB - a higher-order complex of p50:RelA bound to the HIV-1 LTR. J Mol Biol 393: 98-112.
58. Munkanta M, Handema R, Kasai H, Gondwe C, Deng X, et al. (2005) Predominance of three NF-kappaB binding sites in the long terminal repeat region of HIV Type 1 subtype C isolates from Zambia. AIDS Res Hum Retroviruses 21: 901-906. (Pubitemid 43150325)
59. Wires ES, Alvarez D, Dobrowolski C, Wang Y, Morales M, et al. (2012) Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells. J Neurovirol 18: 400-410.
60. Schraufstatter IU, Chung J, Burger M (2001) IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 280: L1094-1103.
61. Langford D, Masliah E (2001) Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol 11: 306-312. (Pubitemid 32494573)
62. D'Aversa TG, Eugenin EA, Berman JW (2008) CD40-CD40 ligand interactions in human microglia induce CXCL8 (interleukin-8) secretion by a mechanism dependent on activation of ERK1/2 and nuclear translocation of nuclear factor-kappaB (NFkappaB) and activator protein-1 (AP-1). J Neurosci Res 86: 630-639. (Pubitemid 351204476)
63. Matsumoto T, Miike T, Nelson RP, Trudeau WL, Lockey RF, et al. (1993) Elevated serum levels of IL-8 in patients with HIV infection. Clin Exp Immunol 93: 149-151. (Pubitemid 23238018)
64. Thea DM, Porat R, Nagimbi K, Baangi M, St Louis ME, et al. (1996) Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1. Ann Intern Med 124: 757-762. (Pubitemid 26117926)
65. Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA, et al. (1998) Chemokines and receptors in HIV encephalitis. Aids 12: 1021-1026. (Pubitemid 28276969)
66. Sopper S, Demuth M, Stahl-Hennig C, Hunsmann G, Plesker R, et al. (1996) The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology 220: 320-329. (Pubitemid 26201690)
67. Cota M, Kleinschmidt A, Ceccherini-Silberstein F, Aloisi F, Mengozzi M, et al. (2000) Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1. J Neurovirol 6: 75-83. (Pubitemid 30175575)
68. Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-1-associated dementia. Nature 410: 988-993.
69. Kaul M, Lipton SA (2006) Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res 4: 307-318. (Pubitemid 44027720)
70. Zheng JC, Huang Y, Tang K, Cui M, Niemann D, et al. (2008) HIV-1-infected and/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-1beta and TNF-alpha: involvement of mitogen-activated protein kinases and protein kinase R. J Neuroimmunol 200: 100-110.
71. Gouwy M, Struyf S, Noppen S, Schutyser E, Springael JY, et al. (2008) Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Mol Pharmacol 74: 485-495.
72. Xing HQ, Hayakawa H, Izumo K, Kubota R, Gelpi E, et al. (2009) In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases. Neuropathology 29: 433-442.
73. D'Aversa TG, Yu KO, Berman JW (2004) Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J Neurovirol 10: 86-97. (Pubitemid 38515067)
74. Jones MV, Bell JE, Nath A (2000) Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS 14: 2709-2713. (Pubitemid 32118724)
75. Mandal D, Prasad VR (2009) Analysis of 2-LTR circle junctions of viral DNA in infected cells. Methods Mol Biol 485: 73-85.
76. Pierson TC, Kieffer TL, Ruff CT, Buck C, Gange SJ, et al. (2002) Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J Virol 76: 4138-4144. (Pubitemid 34250581)
77. Coltart I, Tranah TH, Shawcross DL (2013) Inflammation and hepatic encephalopathy. Archives of biochemistry and biophysics 536: 189-196.
78. Brosnan CF, Raine CS (2013) The astrocyte in multiple sclerosis revisited. Glia 61: 453-465.
79. Kostic M, Zivkovic N, Stojanovic I (2013) Multiple sclerosis and glutamate excitotoxicity. Reviews in the neurosciences 24: 71-88.
80. Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA (2013) Glia and epilepsy: excitability and inflammation. Trends in neurosciences 36: 174-184.
81. Li M, Zhong X, He Z, Wen M, Li J, et al. (2012) Effect of erythromycin on cigarette-induced histone deacetylase protein expression and nuclear factor-kappaB activity in human macrophages in vitro. Int Immunopharmacol 12: 643-650.
82. Vogel CF, Garcia J, Wu D, Mitchell DC, Zhang Y, et al. (2012) Activation of inflammatory responses in human U937 macrophages by particulate matter collected from dairy farms: an in vitro expression analysis of pro-inflammatory markers. Environ Health 11: 17.
83. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, et al. (1987) Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236: 819-822. (Pubitemid 17071156)
84. Burkala EJ, He J, West JT, Wood C, Petito CK (2005) Compartmentalization of HIV-1 in the central nervous system: role of the choroid plexus. AIDS 19: 675-684. (Pubitemid 40593072)
85. Bachu M, Mukthey AB, Murali RV, Cheedarla N, Mahadevan A, et al. (2012) Sequence insertions in the HIV type 1 subtype C viral promoter predominantly generate an additional NF-kappaB binding site. AIDS Res Hum Retroviruses 28: 1362-1368.
86. Naghavi MH, Schwartz S, Sonnerborg A, Vahlne A (1999) Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1. AIDS Res Hum Retroviruses 15: 1293-1303. (Pubitemid 29449408)
87. Evans MC, Couch Y, Sibson N, Turner MR (2013) Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Molecular and cellular neurosciences 53: 34-41.
88. Garau A, Bertini R, Colotta F, Casilli F, Bigini P, et al. (2005) Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia. Cytokine 30: 125-131.
89. Tufekci KU, Meuwissen R, Genc S, Genc K (2012) Inflammation in Parkinson's disease. Advances in protein chemistry and structural biology 88: 69-132.
90. Ransohoff RM, Brown MA (2012) Innate immunity in the central nervous system. The Journal of clinical investigation 122: 1164-1171.